Johnson & Johnson
NYSE: JNJ
$154.77
+$0.77 (+0.5%)
Closing Price on November 18, 2024
JNJ Articles
Chevron, Exxon, 3M, and Johnson & Johnson led all 30 DJIA stocks on a second-consecutive unanimous tumble.
Published:
Last Updated:
24/7 Wall St. has included a calendar of a some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February.
Published:
Last Updated:
Johnson &; Johnson, Gilead Sciences and Amicus Therapeutics are among companies expecting clinical trial and FDA updates in February.
Published:
Last Updated:
Boeing, 3M, Johnson & Johnson, and United Technologies pushed the DJIA to a triple-digit gain Thursday.
Published:
Last Updated:
Travelers and General Electric played big roles in helping the Dow finish basically flat Monday. Johnson & Johnson and Procter & Gamble lagged after tepid quarterly results.
Published:
Last Updated:
Johnson & Johnson reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of GE, Intel, Verizon and other Dow Jones Industrial Average companies due to report their quarterly results this week.
Published:
Last Updated:
Boeing, General Electric, Johnson & Johnson, and United Technologies were Tuesday's pacesetters among the Dow 30 stocks.
Published:
Last Updated:
Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves in 2018.
Published:
Last Updated:
Here is a consensus forecast of each of the 30 Dow Jones Industrial stocks, including a forward 12-month consensus analyst price target and an expected 2018 total return on each.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney and Windstream.
Published:
Last Updated:
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the Dow.
Published:
Last Updated:
Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.
Published:
Last Updated:
These are four quality companies that should continue to do well in 2018. Investors to want to buy the shares and put them in their accounts for a long time.
Published:
24/7 Wall St. tracks key analyst calls in the stocks that move the markets and which are important to investors. It has been almost amazing to see just how many price targets have been raised for...
Published:
Last Updated: